On World Rare Disease Day, our team stands together to show support for those who suffer from rare diseases. For the past ten years, our company has been conducting research on three new therapeutic solutions to improve the lives of rare disease patients. The first project involves developing an AI platform-based treatment for systemic sclerosis&hellip
4Moving Biotech, a subsidiary of 4P-Pharma, announces establishing an international Scientific Advisory Board in anticipation of its knee osteoarthritis drug candidate’s phase 2b clinical trial. “With their expertise in clinical study design and regulatory affairs, this high-level scientific advisory board will greatly contribute to the future success of 4P004, reinforcing our pioneering position in developing&hellip
We are pleased to announce our company’s participation at CHINA Bio 2023, from September 20 – 21, 2023, in Shanghai, China. Our Chairwoman, Revital Rattenbach, and our CEO, Didier Landais, and Francis Berenbaum, CEO/CMO of our subsidiary, 4Moving Biotech, will attend this event. During the event, Pr. Francis Berenbaum will showcase our subsidiary, 4Moving&hellip
All 4P-Pharma’s team wishes you a happy new 2023! Thank you for all your support.